References
- Larsen A, Pettcrsson I, Svensson B. Podophyllum derivatives (CPH-82) compared with placebo in the treatment of rheumatoid arthritis. Br J Rheumatol 1989; 28(2)124–7
- Larsen A. Podophyllum Emodi in rheumatoid arthritis. Scand J Rheumatol 1984; 14: 123, Suppl. 53
- Lerndal T, Nilsson E, Gullberg R. A 24 week clinical study of CPH82/Proresid/Placebo in rheumatoid arthritis. Scand J Rheumatol 1990; 19: 47, Suppl. 85
- Pettersson B, Hedin P-J. Treatment of rheumatoid arthritis with Reumacon. A placebo double-blind controlled study. Scand J Rheumatol 1990; 19: 48, Suppl. 85
- Larsson L-G, Goobar J, Olhagen B. A double-blind randomized trial of CPH82 (Reumacon) and sulfasalazine in rheumatoid arthritis. Scand J Rheumatol 1990; 19: 56, Suppl. 85
- Larsson L-G, Goobar J, Olhagen B. A double-blind randomized trial of CPH82 (Reumacon) and sulfasalazine in rheumatoid arthritis. Unpublished poster presented at XXIII Scandinavian Congress of Rheumatology. TampereFinland 1990
- , et al. Defective hypothalamic response to immune and inflammatory stimuli in patients with rheumatoid arthritis. Arthritis Rheum 1992; 35(11)1281–8